Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Rudolf A Werner^{1

2}, Harun Ilhan³, Sebastian Lehner^{3

4}, László Papp⁵, Norbert Zsótér⁶, Imke Schatka⁷, Dirk O Muegge², Mehrbod S Javadi¹, Takahiro Higuchi^{2

8}, Andreas K Buck², Peter Bartenstein³, Frank Bengel⁹, Markus Essler¹⁰, Constantin Lapa², Ralph A Bundschuh¹¹

Affiliations

¹ The Russell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
³ Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
⁴ Ambulatory Healthcare Center Dr. Neumaier & Colleagues, Radiology, Nuclear Medicine, Radiation Therapy, Regensburg, Germany.
⁵ Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
⁶ Mediso Medical Imaging Systems Ltd., Budapest, Hungary.
⁷ Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁸ Department of Bio Medical Imaging, National Cardiovascular and Cerebral Research Center, Suita, Japan.
⁹ Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
¹⁰ Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany.
¹¹ Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany. ralph.bundschuh@ukbonn.de.

PMID: 30109540
DOI: 10.1007/s11307-018-1261-4

Published Erratum

Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Rudolf A Werner et al. Mol Imaging Biol. 2018 Dec.

. 2018 Dec;20(6):1068.

doi: 10.1007/s11307-018-1261-4.

Authors

Affiliations

¹ The Russell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
³ Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
⁴ Ambulatory Healthcare Center Dr. Neumaier & Colleagues, Radiology, Nuclear Medicine, Radiation Therapy, Regensburg, Germany.
⁵ Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
⁶ Mediso Medical Imaging Systems Ltd., Budapest, Hungary.
⁷ Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁸ Department of Bio Medical Imaging, National Cardiovascular and Cerebral Research Center, Suita, Japan.
⁹ Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
¹⁰ Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany.
¹¹ Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany. ralph.bundschuh@ukbonn.de.

PMID: 30109540
DOI: 10.1007/s11307-018-1261-4

Abstract

The article "Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy," was originally published electronically on the publisher's internet portal without open access.

PubMed Disclaimer

Erratum for

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, Muegge DO, Javadi MS, Higuchi T, Buck AK, Bartenstein P, Bengel F, Essler M, Lapa C, Bundschuh RA. Werner RA, et al. Mol Imaging Biol. 2019 Jun;21(3):582-590. doi: 10.1007/s11307-018-1252-5. Mol Imaging Biol. 2019. PMID: 30014345

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Affiliations

Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources